Keywords: AstraZeneca, Link Medicines, Neuroscience assets, Alzheimer's research, Academic collaboration

AstraZeneca buys Link Medicines neuroscience assets; enters Alzheimer's project

Article | 12 July 2012

Print This

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has acquired a portfolio of neuroscience assets from Link Medicine Corp, a privately held ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in